NewAmsterdam Pharma Company N.V. (NAMS) NASDAQ
32.11
+0.4(+1.26%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
32.11
+0.4(+1.26%)
Currency In USD
| Market Cap | 4.01B |
| Enterprise Value | 3.52B |
| P/E Ratio | -18.28 |
| PEG Ratio | 3.04 |
| Price/Sales Ratio | 166.35 |
| Price/Book Ratio | 5.85 |
| Enterprise/Revenue | 146.08 |
| Enterprise/EBITDA | -14.22 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -9.43 |
| Operating Margin | -9.54 |
| Return On Assets | -0.29 |
| Return On Equity | -0.3 |
| Revenue | 22.5M |
| Revenue/Share | 0.19 |
| Gross Profit | 22.44M |
| EBITDA | -242.33M |
| Net Income | -203.82M |
| Diluted EPS | -1.75 |
| Total Cash | 636.11M |
| Total Cash/Share | 5.25 |
| Total Debt | 23,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 9.76 |
| Book Value Per Share | 5.49 |
| 52-Week Change | 71.8 |
| 52-Week High | 42.21 |
| 52-Week Low | 17.63 |
| Moving Average 50 Days | 33.22 |
| Moving Average 200 Days | 32.92 |
| Average Volume | 1.17M |
| Shares Outstanding | 116.9M |
| % Held by Institutions | 108.06 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |